Lori C Jordan
Overview
Explore the profile of Lori C Jordan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
193
Citations
2434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kassim A, Walters M, Eapen M, Smith M, Logan B, Solh M, et al.
NEJM Evid
. 2025 Feb;
4(3):EVIDoa2400192.
PMID: 39998298
Background: Related human leukocyte antigen (HLA)-haploidentical bone marrow transplantation (BMT) with posttransplant cyclophosphamide may be curative for sickle cell disease. However, graft failure, severe graft-versus-host disease (GVHD), infections, and mortality...
2.
Leguizamon M, Han C, Garza M, Horne M, Richerson W, Davis L, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
PMID: 39993797
Background And Purpose: Anatomical imaging is a hallmark for visualizing chronic and acute infarcts but provides incomplete information on stroke risk. Respiratory hypercapnic gas challenges show promise for non-invasively assessing...
3.
Shiino S, Han C, Garza M, Fusco M, Chitale R, Davis L, et al.
J Neurosurg
. 2025 Feb;
:1-11.
PMID: 39951721
Objective: Both direct and indirect surgical revascularization techniques are commonly applied for the treatment of moyamoya disease and syndrome; however, responses can be heterogeneous and efficacy in the context of...
4.
Han C, Richerson W, Garza M, Rodeghier M, Mishra M, Davis L, et al.
Brain Commun
. 2025 Jan;
7(1):fcae381.
PMID: 39801713
Moyamoya is a non-atherosclerotic intracranial steno-occlusive condition that places patients at high risk for ischaemic stroke. Randomized trials of surgical revascularization demonstrating efficacy in ischaemic moyamoya have not been performed,...
5.
Jordan L, Jones R, DeBaun M, Ford A
Neurology
. 2025 Jan;
104(2):e209737.
PMID: 39746172
No abstract available.
6.
Aumann M, Richerson W, Song A, Martin D, Davis L, Davis S, et al.
Neurology
. 2024 Dec;
104(1):e210191.
PMID: 39705613
Background And Objectives: Sickle cell disease (SCD) is a hemoglobinopathy resulting in hemoglobin-S production, hemolytic anemia, and elevated stroke risk. Treatments include oral hydroxyurea, blood transfusions, and hematopoietic stem cell...
7.
Szuflita N, Chotai S, Feldman M, Dornoff E, Grimaudo H, Vance E, et al.
J Neurosurg Pediatr
. 2024 Nov;
35(2):128-136.
PMID: 39546788
Objective: Pediatric cerebral vasospasm (PCV) is associated with aneurysmal subarachnoid hemorrhage (aSAH), but aSAH is uncommon in children. No universal guidelines exist for PCV management. The authors sought to assess...
8.
Song A, Richerson W, Richerson W, Aumann M, Aumann M, Waddle S, et al.
Blood Adv
. 2024 Nov;
9(2):386-397.
PMID: 39546745
Patients with sickle cell disease (SCD) are at elevated risk of silent cerebral infarcts and strokes; however, they frequently lack established stroke risk factors (eg, macrovascular arterial steno-occlusion) and the...
9.
10.
Carozza R, Horn F, Carter E, Colombo J, Froehler M, Jordan L
Pediatr Neurol
. 2024 Sep;
161:40-42.
PMID: 39265433
No abstract available.